Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Journal of Experimental Hematology ; (6): 1099-1102, 2005.
Artículo en Chino | WPRIM | ID: wpr-343818

RESUMEN

The purpose of study was to investigate the feasibility of the application of cationic propyl gallate (C-PG) as inducer of platelet aggregation for evaluating the platelet function of single-donor plateletpheresis and identifying the incidence of defective platelet function among donors. Experiments were as follows: 3 healthy volunteers' platelet aggregation induced by 100-300 micromol/L C-PG was determined by LG-PABER analyzer to observe the effect of C-PG concentration on platelet aggregation; 30 healthy volunteers' platelet aggregation before and 24 hours after administration of 200-400 mg acetylsalicylic acid (ASA) was examined after induction by 200 micromol/L C-PG for determining the cut-off value to discriminate platelet dysfunction donors; the platelet aggregation of 483 platelet donors was detected and the activated plasma clotting time (APCT) of donors who have deficiency in platelet aggregation was examined for investigating the incidence of defective platelet function among donors. The results showed that platelets were activated by C-PG induction in a dose dependent manner, when concentration of C-PG reached 200 micromol/L, the percentage of platelet aggregation was highest. It significantly decreased after 24 hours with ASA than that before the administration (P < 0.001), especially in 180 seconds induced by C-PG. If cut-off point was fixed on the platelet aggregation < 20% in 180 seconds, donors of platelet dysfunction can be selected effectively. 25 of defective platelet aggregation function among 483 donors were detected, and 11 out of 25 platelet dysfunction donors had the deficiency in procoagulant activity with prolonged APCT. It is concluded that C-PG as inducer of platelet aggregation is feasible to screen the platelet function of donors. Five percent of platelet donors has function defect examined by C-PG as inducer of platelet aggregation.


Asunto(s)
Humanos , Antioxidantes , Química , Farmacología , Aspirina , Donantes de Sangre , Plaquetas , Biología Celular , Fisiología , Cationes , Química , Activación Plaquetaria , Agregación Plaquetaria , Inhibidores de Agregación Plaquetaria , Pruebas de Función Plaquetaria , Transfusión de Plaquetas , Galato de Propilo , Química , Tiempo de Coagulación de la Sangre Total
2.
Journal of Experimental Hematology ; (6): 528-530, 2004.
Artículo en Chino | WPRIM | ID: wpr-352025

RESUMEN

To establish method suitable to assay HCMVpp65 of the blood donors in blood bank and to supply safe blood to the patients, the immunocytochemical techniques were used, (6 - 8) x 10(6)/ml cells were counted, 50 x 10(3) cells were detected by light microscope, The results showed that 10 positive samples in 103 samples were found, positive rate was 9.71%, among 10 positive samples, 2 samples were still positive in the second detecting. In conclusion, this method is simple, quick and effective, suitable to detect HCMVpp65 of the blood donors in the blood bank.


Asunto(s)
Femenino , Humanos , Masculino , Bancos de Sangre , Donantes de Sangre , Inmunohistoquímica , Fosfoproteínas , Sangre , Proteínas de la Matriz Viral , Sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA